Maryland Attorney General Anthony G. Brown has joined forces with a 37-state coalition to urge the Food and Drug ...
Weight-loss drugs are increasingly popular among employees but weigh heavily on health-insurance budgets. Popular weight-loss drugs such as Ozempic, Wegovy and Zepbound are a growing factor in ...
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail ...
A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...
But now, soaring sales of two blockbuster drugs, the anti-obesity and diabetes treatments Wegovy and Ozempic, have turned this pharmaceutical giant into one of Europe's most valuable companies.
The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss.The agency first ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their employers. Weight-loss drugs are increasingly popular among employees ...
It comes after the star revealed that taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' In 2023, Oprah finally admitted to using an undisclosed ...
MEDVi is a telehealth platform designed to provide personalized weight loss solutions through FDA-approved GLP-1 medications such as Semaglutide (Ozempic®, Wegovy®) and Tirzepatide (Mounjaro®).
For two months, 48 people with alcohol use disorder were given either a small weekly shot of semaglutide, the active ingredient in Ozempic and Wegovy, or a placebo. Those who received the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results